glp-1 semaglutide Drug Substantially Reduced Heavy Alcohol Consumption and Weight in Patients with Alcohol Use Disorder and Obesity Retatrutide for Weight Loss: 30 CP Size:15 (on the go packets)

glp-1 semaglutide Drug Substantially Reduced Heavy Alcohol Consumption and Weight in Patients with Alcohol Use Disorder and Obesity Retatrutide for Weight Loss: 30 CP Size:15 (on the go packets)

Retatrutide for Weight Loss: TRIUMPH-1 Results, Cost, Insurance | Klinic

Nature Medicine (2024) Phase 2a trial (98 participants) in which once-weekly retatrutide produced dose-dependent reductions in liver fat in patients with MASLD, with mean relative reductions at 24 weeks of 81.4% (8mg) and 82.4% (12mg)

30 CP

Size:15 (on the go packets)

This dual mechanism appears to produce even greater effects on blood sugar and body weight than GLP-1-only medications